Single intratracheal administration toxicity study on safety of vapor inhalation of electrolyzed reduced water in rats.

The effects of acute intratracheal administration of electrolyzed reduced water (ERW; alkaline electrolyzed water) were investigated in rats. In this study, no deaths or near-deaths were recorded in either group, namely those treated with ERW or purified water (maximum doses of 900 mg/kg). The main symptoms observed in the rats were decreased spontaneous movements and abnormal breath sounds, which were considered to be transient symptoms caused by intratracheal administration. In addition, low values of alkaline phosphatase, total protein and lactate dehydrogenase were found in BALF tests, but these values were considered to be of low toxicological significance, since they are usually high in the presence of lung inflammation or cellular damage. This suggests that the alkalinity of ERW partially contributes to broken peptide bonds in proteins. There were no significant increases in bronchoalveolar lavage fluid protein in either group. ERW did not cause an increase in the influx of neutrophils, eosinophils, basophils, or lymphocytes, suggesting that intratracheal administration of ERW did not cause lung inflammation. ERW did not cause abnormalities in the body or pathological changes in the lungs. Aggregates of alveolar macrophages, as a measure of inflammation, were observed in both groups. These may be transient symptoms due to intratracheal administration, not due to ERW toxicity. This study confirmed the safety of intratracheal ERW infusion and demonstrated the low risk of acute toxicity for inhalation exposure to ERW aerosol or vapor. Therefore, ERW may be an effective air purifier against viruses or bacteria.

Physicochemical properties and detergency of special electrolytic-reduction ion water.

The detergency of special electrolytic-reduction ion water (S-100) was evaluated in comparison with typical synthetic surfactants. Furthermore, to examine the cleaning mechanism of S-100, various physicochemical characteristics of S-100 were measured and a comprehensive evaluation of cleaning was performed. S-100 (10%) had a detergency comparable to that of various surfactants, such as sodium dodecyl sulfate and sodium dodecyl benzene sulfonate, which are generally blended or mixed in residential detergents. In addition, concentrated aqueous solutions of 10% or more of S-100 showed stronger detergency. The cleaning mechanism of S-100 is mainly attributed to the effect of surface tension reduction due to dissolved hydrogen or hydrogen nanobubbles in S-100, and the alkalinity generated by electrolysis charged the surface of the dirt or adherend, resulting in a peeling effect.

Antiviral effect of electrolyzed reduced water on SARS-CoV-2.

The inhibitory activity of electrolyzed reduced water (ERW) against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which is the etiological agent responsible for coronavirus disease 2019 (COVID-19), was tested in vitro on Vero E6 cells using a plaque assay. Infectious virus titers of cells treated with ERW 100%, 50% and 33.3% solutions and phosphate buffered saline (PBS, negative control) and exposed to the virus suspension for 60 seconds were 2.25, 2.65, 3.21 and 7.38, respectively. ERW has a high pH and low surface tension. It is considered that the alkaline property of ERW breaks down phospholipids and proteins of envelopes. The role of pH and reducibility on the virucidal effect of ERW should be further evaluated. This study provides a foundation for utilizing ERW as an effective antiviral aqueous solution in a variety of applications.

Electrolytic-reduction ion water induces ceramide synthesis in human skin keratinocytes.

Ceramides play a critical role in the skin barrier. We previously demonstrated that electrolytic-reduction ion water (ERI) improves skin integrity and enhances the protective barrier function of the epidermis. Here, we first examine the effect of ERI on the expression of ceramide synthesis-related enzymes in human skin keratinocytes. The expression of enzymes involved in the elongation of very-long-chain fatty acids protein 4 (ELOVL4) was increased after treatment with ERI-containing media. The expression of ceramide synthase 3 (CerS3), which binds ultra-long-chain fatty acids to sphingosine to produce ceramides found in the skin, was also increased. Subsequently, we examined the expression of ceramides in keratinocytes treated with ERI using thin-layer chromatography. The results showed that ERI increased the ceramide content, and these ceramides were more hydrophobic than those extracted from untreated keratinocytes. These results suggest that ERI enhances the expression of enzymes involved in the synthesis of ceramides containing ultra-long-chain fatty acid residues, which have a protective function in the skin.